Achilles Therapeutics Plc Overview

Achilles Therapeutics Plc Other Income Expense Net

Other Income/Expense Net for ACHL.

Quarterly Other Income/Expense

$817000.00

↓ 65.8% YoY

As of Sep 30, 2024

Annual Other Income/Expense (TTM)

$5.65M

↑ 60.85% YoY

Trailing 12 months ending Sep 30, 2024

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin